CN102309486A - The anti-cancer of pancreas effect and the pharmaceutical preparation thereof of piperine - Google Patents
The anti-cancer of pancreas effect and the pharmaceutical preparation thereof of piperine Download PDFInfo
- Publication number
- CN102309486A CN102309486A CN201010533624A CN201010533624A CN102309486A CN 102309486 A CN102309486 A CN 102309486A CN 201010533624 A CN201010533624 A CN 201010533624A CN 201010533624 A CN201010533624 A CN 201010533624A CN 102309486 A CN102309486 A CN 102309486A
- Authority
- CN
- China
- Prior art keywords
- piperine
- pharmaceutical preparation
- cancer
- pharmaceutical
- pancreas
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses the new medical use of piperine aspect anti-cancer of pancreas, also disclosing with the piperine simultaneously is that pharmaceutical raw material is prepared into acceptable drug preparation clinically such as tablet, capsule, pill, injection.Piperine pharmaceutical preparation of the present invention contains the piperine of 1%-99% and the pharmaceutical excipient of 99%-1% (comprising the medicine that other compatibility is used).Piperine provided by the invention and pharmaceutical preparation thereof have good anti-cancer of pancreas effect, show that the vitro human pancreatic cancer cell is had obvious inhibiting activity, and the transplanted tumor in nude mice of this tumor cell is had significant antitumor activity.In addition, the active component of this pharmaceutical preparation is a Chinese medicine extract, abundant raw material and have the little advantage of toxic and side effects.
Description
One, technical field
The present invention relates to application and the pharmaceutical preparation thereof of piperine (Piperine) aspect anti-cancer of pancreas medicine, belongs to the field of Chinese medicines.
Two, background technology
Malignant tumor is the commonly encountered diseases and the frequently-occurring disease of serious threat human health, and the exploitation of cancer therapy drug has become the key subjects of new drug research in this century.At present, from plant, seek the antitumor drug of high-efficiency low-toxicity, become the emphasis of domestic and international antitumor drug research.We find that in the screening antineoplastic drugs process piperine has the effect of very strong inhibition pancreatic cancer cell and solid tumor growth.
Piperine is mainly derived from Piperaceae plants such as black pepper, is white crystalline powder.130~133 ℃ of fusing points are dissolved in acetic acid, benzene, ethanol and chloroform, are slightly soluble in ether.Piperine molecular weight: 285.34; Molecular formula: C
17H
19NO
3Chemical name: (E, E)-1-[5-(1,3-Benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]-piperidine; (E, E)-1-[5-(1,3-benzo dioxolanes-5-yl)-1-oxo-2,4-pentadienyl]-piperidines.
Chemical structural formula:
Before the present invention, do not find with the piperine to be feedstock production pharmaceutical dosage form and the report that is used to prevent and treat the cancer of pancreas disease.Piperine is almost non-toxic, and natural resources of Chinese medicinal materials is very abundant, is a kind of very promising antitumor drug.
Three, summary of the invention
One of the object of the invention has provided the pharmaceutical preparation of piperine;
Two of the object of the invention has provided the antineoplastic new usage of piperine.
The objective of the invention is to realize through following technical scheme:
Pharmaceutical preparation of the present invention contains the piperine of 1%-99% and the excipient of 99%-1% (medicine that comprises other adapted); Preferably contain the piperine of 20%-80% and the excipient of 80%-20% (medicine that comprises other adapted), preferably contain the piperine of 60%-70% and the excipient of 40%-30% (medicine that comprises other adapted).
Press practice of pharmacy, can piperine of the present invention be prepared into the various clinical pharmaceutical dosage form as anti-cancer of pancreas medicine, comprise the dosage form of oral formulations or parenterai administration.Said oral formulations selects any in tablet, capsule, pill, granule, microcapsule tablet, suspensoid, drop pill, oral liquid; Said parenterai administration dosage form is selected from a kind of in the middle of injection, aerosol, suppository or the subcutaneous administration dosage form.
Adjuvant in the anti-cancer of pancreas medicine of the present invention is meant conventional excipient, like solvent, disintegrating agent, correctives, antiseptic, coloring agent, binding agent etc.The medicine that other compatibility in the antitumor drug of the present invention is used, the piperine that refers to effective dose is certain medicine material, again compatibility other allowed the Chinese medicine or the chemical drugs that share.
Piperine pharmaceutical preparation of the present invention has anti-cancer of pancreas effect, is to be confirmed through following pharmacodynamics test.
Test Example 1 has been investigated the inhibitory action of piperine to external pancreatic cancer cell
Cell: human pancreas cancer epithelial cell (PANC-1).For ocean institute of Chinese Academy of Sciences marine drug laboratory provides.
Medicine and reagent: ocean institute of piperine (Piperine) Chinese Academy of Sciences marine drug laboratory provides white powder; 5-fluorouracil (5-FU) Nantong elite pharmaceutical Co. Ltd product, lot number is 100402; MTT (SIGMA, USA); DMSO (SIGMA, USA); Trypsin SIGMA, USA); RPMI1640 (GIBCO, Invitragen Co., USA); DMEM (GIBCO, Invitragen Co., USA); The top grade hyclone (GIBCO, Invitragen Co., USA); Superfine hyclone Fetal Bovine Serum (Hyclone).
Instrument: ultra cold storage freezer (Nature, USA), cell culture incubator (SANYO, Japan); Inverted microscope (NIKON, Japan), ELIASA (Bio-Tek Instruments; Inooski, VT, USA); The PH meter (Thermo orion, USA), superclean bench (FLC-Harbin Dong Lian instrument plant).
Experimental technique mtt assay: tumor cell line is gone down to posterity according to the conventional method cultivation, collect the exponential phase cell, regulate concentration of cell suspension 5 * 10
4About individual/ml.Cell suspension is added in 96 well culture plates, and each hole adds 180 μ l, place 37 ℃ of constant incubators to cultivate 24 h after.Respectively piperine and 5-FU are made into the solution of variable concentrations with cell culture medium, experimental group adds each concentration piperine (with 5-FU as positive controls) 20 μ l/ holes, establishes 4 parallel holes for every group, and establishes blank well (cell culture medium) with zeroing.37 ℃ of incubators, cultivate 48 h after, with liquid-transfering gun liquid in 96 orifice plates is cleaned every hole, back and adds MTT (1 mg/ml) 30 μ l, put CO
2Incubator is cultivated 4 h for 37 ℃, supernatant discarded, and every hole adds DMSO 150 μ l, puts shaking table and shakes up 30 min, detects under 492 nm with ELIASA, utilizes the SPSS statistical software, calculates cell mortality, asks for IC
50
Result of the test shows; Through the SPSS software statistics; The piperine of variable concentrations has inhibitory action in various degree to the human pancreas cancer epithelial cell (PANC-1) that is used to test, and is certain dose-dependence, and the piperine of variable concentrations is to suppression ratio, the IC of pancreatic cancer cell
50Value sees table 1 for details.
The piperine of table 1 variable concentrations is to the suppression ratio of pancreatic cancer cell
Test Example 2 piperines are to the tumor-inhibiting action of pancreatic cancer cell transplanted tumor in nude mice
Laboratory animal: the BALB/c nude mice is available from Shanghai Slac Experimental Animal Co., Ltd., and animal licence numbering: SYXK (Shanghai) 2010-0047, totally 20, in 7 ~ 9 ages in week, body weight 20 ~ 22g is male Mus.Animal feeding and experiment are raised in the Affiliated Hospital of Qingdao University Experimental Animal Center for no special pathogen level barrier system.
Tumor cell inoculation: the human pancreas cancer epithelial cell (PANC-1) of the trophophase of taking the logarithm is processed tumor cell suspension (1 * 10
7Individual/as ml), to implant BALB/c male nude mouse armpit subcutaneous (about 0.3ml/ only), situation such as inoculation back routine observation mice spirit, diet and defecation.After going down to posterity once, with the aseptic taking-up of tumor tissues and be cut into big or small identical 2mm
3Fritter, it is subcutaneous to be seeded in the nude mice armpit with the trocar.
Test is divided into groups and method: the major diameter of vernier caliper measurement tumor nodule (a), minor axis (b), by formula V=a * b
2* 0.52 calculates gross tumor volume, when subcutaneous transplantation tumor length to 100 mm
3After, selecting tumor nude mice of the same size, nude mice is weighed is divided into 3 groups with the table of random number method, is respectively negative control group, positive controls, piperine group, every group of 5 nude mices.Respectively piperine and 5-FU are made into the solution of variable concentrations, drug level and concrete the grouping as follows: (1) negative control group: lumbar injection 0.2ml normal saline with cell culture medium; (2) positive drug matched group: the 5-FU of lumbar injection 30mg/kg; (3) piperine group: 15mg/kg lumbar injection.Injection in per 3 days is once injected 10 times continuously, behind last administration 24 h, takes out the tumor piece, and it is heavy to measure tumor, calculates average tumor control rate at last.Adopt the SPSS software statistics, test data is with (average ± standard deviation) expression, and P is a significant difference significance criterion of meaning less than 0.01.Result of the test is seen table 2.
Table 2 piperine is to the inhibitory action result of the test of PANC-1 transplanted tumor in nude mice (`X ± SD)
Annotate: compare * * P < 0.01 * P < 0.05 with matched group
Visible by table 2; The transplanted tumor in nude mice of piperine treatment group and 5-FU treatment group has all received inhibition in various degree than matched group; The piperine group is superior to positive drug matched group (5-FU) 30mg/kg administration with the tumor killing effect of 15mg/kg administration; In addition, the piperine group is very little to the influence of nude mice body weight, shows that tentatively piperine does not have obvious toxic-side effects.
Above-mentioned isolated test and bulk testing show that piperine all has the obvious suppression effect to stripped with whole man's pancreatic cancer cell (PANC-1), and does not have obvious toxic-side effects, and the prompting piperine is a kind of very promising anti-cancer of pancreas medicine.
Four, the specific embodiment
The preparation of embodiment 1 tablet
Piperine 1000g, medical starch 100g, mix homogeneously is granulated as binding agent with an amount of ethanol, drying, through the pelletizing machine granulate, tabletting, every 0.30g, oral, each 1-2 sheet, twice of every day.
The preparation of embodiment 2 capsules
Piperine 1000g, medical starch 100g, mix homogeneously is granulated as binding agent with an amount of ethanol, and drying is crossed 120 mesh sieve granulate, dress 0# capsule, every 0.300g, each oral 1-2 grain, twice of every day.
The preparation of embodiment 3 drop pills
Polyethylene Glycol
4000400g melts in water-bath, adds piperine raw material 250g; Stir, in the impouring insulating tube, regulate thermostat; Make medicinal liquid under 80-90 ℃, splash in the liquid paraffin that cooled off (temperature ± 4 ℃), after dripping off, with blotting liquid paraffin on the pill impouring filter paper; Add a small amount of Pulvis Talci again, mixing gets 10000 of piperine drop pill.Oral, one time four, three times on the one, one after each meal.
The preparation of embodiment 4 granules
Piperine raw material 100g, starch 1000g, Icing Sugar 500g, mix homogeneously is used an amount of alcohol granulation, and drying, granulate, packing promptly get.Oral, a 5g, twice on the one.
The preparation of embodiment 5 microencapsule tablets
Take by weighing stearic acid 12g and 18ml Herba Origani oil respectively as compound recipe capsule material, take by weighing piperine 80g as capsule core material, through the spray congealing encystation, capsule directly is 10-100 μ m with compressed air.With microcapsule and microcrystalline Cellulose mixing, add the mixed encystation material of 12% ethyl cellulose alcoholic solution then, process granule through 18 order nylon mesh; In oven dry below 50 ℃, placed exsiccator interior 24 hours, add 1%-3% magnesium stearate tabletting; Get the piperine microencapsule tablet, sheet heavily is 0.4g, and is oral; A 1-2 sheet, twice on the one.
The preparation of embodiment 6 injections
Piperine 40g, propylene glycol 50ml, PEG400 100ml, water for injection 600ml; Mix, heating in water bath 30 minutes adds benzyl alcohol 90ml, and reuse water for injection adds to 1800ml; In ultrasound wave, handled 10 minutes, in water-bath, heated 30 minutes, adjust pH is 5.5-6.5; Filter, embedding, sterilization promptly gets.Every 3ml, intramuscular injection, a 3ml, twice on the one.
Claims (9)
1. pharmaceutical preparation that is used to treat cancer of pancreas is characterized in that containing the piperine of treating effective dose and one or more pharmaceutically acceptable pharmaceutical excipients, or can with the other medicines of piperine prescription.
2. pharmaceutical preparation according to claim 1, but it is characterized in that containing piperine and the pharmaceutical excipient of 99%-1% or the medicine of other prescription of 1%-99%.
3. pharmaceutical preparation according to claim 2, but it is characterized in that containing piperine and the pharmaceutical excipient of 80%-20% or the medicine of other prescription of 20%-80%.
4. pharmaceutical preparation according to claim 3, but it is characterized in that containing piperine and the pharmaceutical excipient of 40%-30% or the medicine of other prescription of 60%-70%.
5. pharmaceutical preparation according to claim 1 is characterized in that said medicine is the dosage form of oral formulations or parenterai administration.
6. pharmaceutical preparation according to claim 5 is characterized in that said oral formulations is selected from any in tablet, pill, capsule, granule, microcapsule tablet, suspensoid, drop pill, the oral liquid.
7. pharmaceutical preparation according to claim 5 is characterized in that said parenterai administration dosage form is selected from any in the middle of injection, aerosol, suppository or the subcutaneous administration dosage form.
8. the application of piperine in the anti-cancer of pancreas medicine of preparation.
9. according to Claim 8 purposes is characterized in that said anti-cancer of pancreas is meant the growth that suppresses human pancreas cancer epithelial cell (PANC-1) and nude mice transplanted tumor thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010533624A CN102309486A (en) | 2010-11-07 | 2010-11-07 | The anti-cancer of pancreas effect and the pharmaceutical preparation thereof of piperine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010533624A CN102309486A (en) | 2010-11-07 | 2010-11-07 | The anti-cancer of pancreas effect and the pharmaceutical preparation thereof of piperine |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102309486A true CN102309486A (en) | 2012-01-11 |
Family
ID=45423309
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010533624A Pending CN102309486A (en) | 2010-11-07 | 2010-11-07 | The anti-cancer of pancreas effect and the pharmaceutical preparation thereof of piperine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102309486A (en) |
-
2010
- 2010-11-07 CN CN201010533624A patent/CN102309486A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102166260B (en) | Clove extract with tumor resisting effect and pharmaceutical preparation thereof | |
CN101965185A (en) | Use of tea polyphenols in preparing medicaments for prevention or treatment of tumors | |
CN102846667B (en) | Preparation method for nanometer Periplaneta americana through low temperature drying | |
CN102309487A (en) | The antihepatocarcinoma effect of piperine and pharmaceutical preparation thereof | |
CN103893188A (en) | Application of ilexgenin A in preparation of anti-tumor medicaments | |
CN104337823B (en) | A kind of pharmaceutical composition inhibiting tumour | |
CN102151275A (en) | Pancreatic cancer-resisting effect of oleanolic acid and pharmaceutical preparation of oleanolic acid | |
CN102133219A (en) | Anti-cervical cancer effect of oleanolic acid and pharmaceutical preparation thereof | |
CN102114059A (en) | Nutmeg extract with antitumor effect and medicinal preparation thereof | |
CN110302386A (en) | Combination product comprising limonoid and sulfonylureas | |
CN102309485A (en) | The effect of resistive connection intestinal cancer and the pharmaceutical preparation thereof of piperine | |
CN102309484A (en) | The effect of anti-lung cancer of piperine and pharmaceutical preparation thereof | |
CN102670572A (en) | Synthesis and application of bis(2,3-dibromo-4,5-dihydroxybenzyl) ether | |
CN102106858A (en) | Anti-cervical carcinoma effect of maslinic acid and medicinal preparation thereof | |
CN102151276A (en) | Pancreatic cancer resistance effect and pharmaceutical preparation of crataegolic acid | |
CN102106859A (en) | Breast cancer-resisting function and pharmaceutical preparation of maslinic acid | |
CN102106861A (en) | Anti-colon cancer effect of maslinic acid and medicinal preparation thereof | |
CN102091078A (en) | Maslinic acid anti-hepatocarcinoma effect and maslinic acid medicinal preparation | |
CN101780071B (en) | Application of osthole in preparation of medicament for preventing and treating myocardial fibrosis | |
CN102309486A (en) | The anti-cancer of pancreas effect and the pharmaceutical preparation thereof of piperine | |
CN102114022A (en) | Application of oleanolic acid in resisting colon cancer and pharmaceutical preparations thereof | |
CN102106860A (en) | Anti-liver-cancer effect of Oleanolic acid and pharmaceutic preparation | |
CN102114021A (en) | Application of oleanolic acid in resisting breast cancer and pharmaceutical preparations thereof | |
CN102114023A (en) | Oleanolic acid with anti-oophoroma action and pharmaceutical preparations thereof | |
CN101978992A (en) | Black pepper extract with anti-tumor effect and medicinal preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120111 |